LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 58.21 | 17.25 | 1 | 4942 | 0.0002 | -0.2945 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 58.21 | 17.25 | 2727 | 4942 | 0.5518 | 0.8595 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 58.21 | 17.25 | 8 | 4942 | 0.0016 | -0.0899 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 58.21 | 17.25 | 2861 | 4942 | 0.5789 | 0.8704 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 60.18 | 17.25 | 1 | 5031 | 0.0002 | -0.2938 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 60.18 | 17.25 | 2824 | 5031 | 0.5613 | 0.8638 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 60.18 | 17.25 | 11 | 5031 | 0.0022 | -0.0535 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 60.18 | 17.25 | 3017 | 5031 | 0.5996 | 0.8789 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 63.15 | 17.25 | 1 | 5061 | 0.0002 | -0.2935 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 63.15 | 17.25 | 2996 | 5061 | 0.5920 | 0.8761 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 63.15 | 17.25 | 11 | 5061 | 0.0022 | -0.0534 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 63.15 | 17.25 | 3203 | 5061 | 0.6329 | 0.8914 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 65.12 | 17.25 | 1 | 5095 | 0.0002 | -0.2932 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 65.12 | 17.25 | 3221 | 5095 | 0.6322 | 0.8913 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 65.12 | 17.25 | 16 | 5095 | 0.0031 | -0.0091 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 65.12 | 17.25 | 3342 | 5095 | 0.6559 | 0.8998 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 67.09 | 17.25 | 1 | 5221 | 0.0002 | -0.2922 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 67.09 | 17.25 | 3345 | 5221 | 0.6407 | 0.8948 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 67.09 | 17.25 | 10 | 5221 | 0.0019 | -0.0640 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 67.09 | 17.25 | 3539 | 5221 | 0.6778 | 0.9078 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 69.06 | 17.25 | 1 | 5242 | 0.0002 | -0.2920 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 69.06 | 17.25 | 3463 | 5242 | 0.6605 | 0.9019 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 69.06 | 17.25 | 12 | 5242 | 0.0023 | -0.0431 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 69.06 | 17.25 | 3703 | 5242 | 0.7063 | 0.9174 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 71.03 | 17.25 | 1 | 5367 | 0.0002 | -0.2910 | MN20160310_N02 | F13 |